JEFFREY GRASMEDER: Open Payments
NPI 1730669987 · CONNELLSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 50 payments from 14 companies in 2025. Trend: 2023 $184 · 2024 $955 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $419 |
| Novo Nordisk Inc | 14 | $234 |
| Verona Pharma, Inc. | 10 | $149 |
| Amgen Inc. | 5 | $87 |
| Eisai Inc. | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: BREZTRI, FARXIGA, Ohtuvayre, Rybelsus, OTEZLA, Wegovy, Leqembi, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
